Patents by Inventor Toby Jonathan Blench

Toby Jonathan Blench has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7208494
    Abstract: The present invention provides piperazine derivatives of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in the description. They can be used for the treatment of obesity.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: April 24, 2007
    Assignees: Hoffmann-La Roche Inc., Vernalis Research Limited
    Inventors: Toby Jonathan Blench, Paul Hebeisen, Hans Richter, Stephan Roever
  • Patent number: 7098337
    Abstract: The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts, solvates and esters thereof. These compounds can be used to prepare pharmaceutical compositions for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
    Type: Grant
    Filed: January 24, 2003
    Date of Patent: August 29, 2006
    Assignees: Hoffmann-La Roche Inc., Vernalis Research Limited
    Inventors: David Reginald Adams, Jonathan Mark Bentley, Toby Jonathan Blench, Paul Hebeisen, Nathaniel Julius Thomas Monck, Hans Richter, Stephan Roever, Jonathan Richard Anthony Roffey, Sven Taylor
  • Publication number: 20030207888
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: January 24, 2003
    Publication date: November 6, 2003
    Inventors: David Reginald Adams, Jonathan Mark Bentley, Toby Jonathan Blench, Paul Hebeisen, Nathaniel Julius Thomas Monck, Hans Richter, Stephan Roever, Jonathan Richard Anthony Roffey, Sven Taylor